cancer final review

Embed Size (px)

Citation preview

  • 8/7/2019 cancer final review

    1/31

    Cancer Concepts Winter, 2011

    Final Review

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    2/31

    What Well Try to Cover:ImportantPoints to Know

    What agents can cause cancer? How do cancer cells develop from normal cells?

    What is the difference between hyperplasia, metaplasia, dysplasia, carcinoma in situ,

    invasive cancer, and neoplasia?

    What is an oncogene? Know some examples of oncogenes and how they function.

    What is a tumor suppressor gene? Know some examples of tumor suppressor genesand how the function.

    What pathologic changes do cells undergo as they transform from normal to cancer?

    What are protein kinases?

    What is involved in the process of metastasis?

    a s ang ogenes s an w y o cancers nee Do cancer metastases pop up randomly? If not, know some sites that some tumors like

    to go to.

    What are the ma or reasons that sur er is used when a roachin cancer?

    What are the major reasons that radiation is used when approaching cancer?

    What are the major reasons that drugs are used when approaching cancer?CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    3/31

    What Well Try to Cover:ImportantPoints to Know continued

    Have a general understanding of chemotherapy drugs by class alkylators, anti-

    metabolites, topoisomerase inhibitors, microtubule binding drugs, platinum

    analogues, immune therapies, antibodies, tyrosine kinase inhibitors, others

    What is the role of palliative care in cancer treatment? What interventions work to revent cancer? How do the work?

    What cancer screening techniques are effective? What makes a cancer screen an

    effective screen?

    What is the difference between stage and grade of cancer? Have a general sense of

    s ages o cancer How is pediatric oncology different from adult oncology?

    What long term health issues might survivors of cancer have to deal with?

    How can ou explain differences in the incidence of cancer around the world?

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    4/31

    Agents That Cause Cancer

    Chemical Tobacco, Solvents, Pesticides

    Physical Asbestos, Chronic Irritation

    Radiation UV, Ionizing Viral HPV, HIV, EBV, HTLV-I

    Bacterial H.Pylori

    Parasitic Schistosomes, Liver Flukes

    Think about how these cause cancer!

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    5/31

    ow o ancer e s eve opFrom Normal Cells?

    Acquisition of Genetic Changes

    Loss of Tumor Suppressor Function

    Common TP53, Rb

    Common TEL, EGFR, HER2, KRAS, MYC, etc.

    Mor holo ic Chan es

    Normal Hyperplasia Dysplasia CIS

    Invasion

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    6/31

    at s t e erence etweenhyperplasia, metaplasia, dysplasia,

    , ,and neoplasia?

    yperp as a ncrease n um er o e s

    Metaplasia Transformation of One Cell Type Into

    Another Dysplasia Abnormal Development of Cells

    Carcinoma in situMalignant Cells That Have NotInvaded Into Tissue

    Invasive Cancer Malignant Cells That Have InvadedInto Tissue and Can Spread Further

    Neo lasia New Cell Growth Does Not NecessarilRefer to Benign or Malignant

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    7/31

    What is an oncogene?Know some examples of oncogenes

    an ow t ey unct on.-

    Normal Cell Growth

    Normal Functions:

    Growth Factors (sisB Chain of PDGF)

    Receptors (erb-2HER2, EGFR)

    Intracellular Signal Transduction (src, abl, KRAS)

    Nuclear Transcription Factors (myc, hox)

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    8/31

    Know some examples of tumor

    function.

    Normal Function Blocks Cell Proliferation

    Normal Function Leads To DNA Repair Normal Function Leads to Apoptosis

    Examples Rb, TP53, APC

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    9/31

    undergo as they transform from

    Morphologic Changes

    Normal Hyperplasia Dysplasia CIS

    Invasion

    Pleomorphism

    Condensed Chromatin

    Loss of Polarit

    Anchorage Independent Growth

    Loss of Contact Inhibition CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    10/31

    What Are Protein Kinases?

    Kinases add phosphate (PO3=) to proteins

    acids that are phosphorylated

    Lar e MW=80 char ed PO = inducesconformational change on protein

    Conformational change affects protein

    function

    ATP or GTP are PO3= donors

    Protein kinases are drug targetsCC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    11/31

    What is involved in the process ofmetastasis?

    Cellular DiscohesionCells arenormally anchored to basementmembranes, the extra-cellular matrix, and adjacent cells. These

    .

    Invasion Through Basement Membrane The basement membrane mustbe destroyed. This will require enzymes. To get through the basement

    membrane, theremust be cell motility. .

    Survival in Blood/Lymph The cancer cell must avoid immune surveillance

    Exit From Blood/Lymphatic Vessel See Invasion intoblood/lymphaticvessel

    Growth in Foreign Soil Metastasis necessarily means the ability to growin an environment that is foreign to the one the cell originated in. Theremust be an ability to tolerate and thrive in new conditions.

    Recruitment of New Vasculature In the absence of blood vessels, growtho a co ony o ce s s m e y e us on o oxygen an nu r en s.

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    12/31

    a s ang ogenes s an w y ocancers need it?

    450 m Hepatoma Cell

    Spheroid

    Green Cells At Rim Are Viable

    Red Cells in Center are

    Necrotic

    NO Blood Flow = NO Life

    Molecular Therapy(2009) 17 8, 14041410CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    13/31

    cancers need it?

    Degradation of Basement

    Membrane of Existing

    Vessel

    Migration of Endothelial

    Cells into Interstitium

    Endothelial Cell Proliferation

    Lumen Formation

    Generation of New

    Basement Membrane

    Fusion of Newly Formed

    VesselsCC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    14/31

    Do cancer metastases pop uprandomly? If not, know some sites

    a some umors e o go o.

    Cancer Metastases Do NOT Appear at Random

    Preferred Sites of Spread for Selected Cancers:

    Lung Cancer: Bones, Liver, Adrenal Glands, Brain

    , , ,

    Colon Cancer: Liver, Abdominal Cavity, Lungs

    Prostate Cancer: Bones

    Pancreatic Cancer: Liver, Abdominal Cavity Renal Cell Carcinoma: Lungs, Bones, Brain

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    15/31

    at are t e ma or reasons t atsurgery is used when approaching

    Biopsy for Diagnosis

    Complete Resection for Cure

    R0: Complete Resection, Negative Margins : ross y omp e e esec on,

    Microscopically Positive Margins

    R2: Grossly Incomplete Resection

    Metastatectomy Possibly for ?Cure?

    Palliation Relief of Obstruction, Bleeding, Pain, etc.

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    16/31

    What are the major reasons thatradiation isused when approaching

    cancer? Radical Radiation for Cure

    Adjuvant Radiation After Surgery

    Improve Local Control Improve Survival

    Palliative Radiation

    Control Bleeding

    O en Airwa s

    ?Prolong Life? (Cranial Radiation for Mets)

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    17/31

    at are t e ma or reasons t at rugsare used when approaching cancer?

    Curative Chemotherapy

    Leukemia, Lymphoma, Germ Cell Cancer

    Adjuvant Chemotherapy Improve Survival After Surgical Resection

    Improve Survival When Given With Radiation

    a a ve emo erapy Relieve Pain, Dyspnea, Performance Status

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    18/31

    Have a general understanding ofchemotherapy drugs by class

    alkylators, anti-metabolites,topoisomerase inhibitors, microtubulen ng rugs, p a num ana ogues,

    immune therapies, antibodies, tyrosine,

    ec an sm o c on Metabolism

    Toxicity

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    19/31

    asses an ec an sms oChemotherapy Drugs

    Alkylators: Cyclophosphamide, Nitrogen Mustard

    Anti-metabolites: Fluorouracil (Capecitabine),

    Cytarabine, Gemcitabine, Methotrexate, Fludarabine opo somerase n ors: oxoru c n, opos e,

    Irinotecan

    Microtubule Bindin Dru s: Vincas Taxanes

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    20/31

    asses an ec an sms oChemotherapy Drugs

    Immune Thera ies: Interferon IL-2

    Antibodies: Trastuzumab, Cetuximab, Rituximab

    TK Inhibitors: Erlotinib, Sunitinib, Lapatinib Platinum Compounds: Cisplatin, Carboplatin,

    Oxaliplatin

    ormona gen s: amox en, roma ase n ors(Anastrazole), LHRH Agonists

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    21/31

    Metabolism of Chemotherapy Drugs

    Primarily Renal Platinum Analogues, Methotrexate,

    Bleomycin

    Primarily Hepatic Taxanes, Vincas, Anthracyclines,

    ,

    Primarily Intracellular 5-FU, Gemcitabine,

    Cytarabine, Fludarabine

    Also Prodrugs Cyclophosphamide, Capecitabine, Irinotecan,

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    22/31

    Toxicity of Chemotherapy Drugs

    Myelosuppression Common

    xcept ons: ncr st ne, eomyc n, s,

    Antibodies, Cisplatin

    , ,

    Nitrosureas

    Renal Cisplatin

    Neurotoxicity Vincristine, Taxanes, Cis-/Oxalo-platin

    ,

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    23/31

    What is the role of palliative carein cancer treatment?

    not just at the end

    Relieve s m toms of disease and treatment

    Focus on prognosis

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    24/31

    cancer? How do they work?

    Tobacco Cessation

    Diet and Cancer

    No evidence for supplements

    Surgery to Prevent Cancer n cancer am y syn romes

    Drugs to Prevent Cancer

    Finasteride: Prostate Cancer

    ,

    Vaccines to Prevent Cancer

    Hepatitis B: Hepatocellular Cancer

    Pa illoma Viruses: Cervical Head and Neck Cancers

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    25/31

    effective? What makes a cancer

    Definitely Effective Screens

    Colonoscopy, Fecal Occult Blood for Colorectal Cancer

    Pap Smear for Cervical Cancer Maybe Useful Screens

    Chest CT in Smokers for Lung Cancer

    Liver Scan/AFP in HB/CV(+) for Hepatoma

    Definition of Effective Screen Reduces Morbidity and Mortality of Screened Cancer,

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    26/31

    of cancer? Have a general sense of stages ofcancer.

    Staging

    Films, Physical Exam

    Grading

    Histology

    Strong Prognostic Value

    Strong Therapeutic Value

    Some Prognostic Value

    Little Therapeutic Value

    Uses T, N, M System Uses Morphologic Guidelines

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    27/31

    Staging Generalities

    Stage I Small Tumor, Negative Nodes

    Stage II Larger Tumor or Tumor Invades Deeper

    Structures, Negative Nodes or Only Immediate Nodal

    Grou

    Stage III Larger Tumor or Positive Nodes

    Stage IV Distant Metastatic Disease

    There Are Exceptions To The Above Guide!

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    28/31

    ow s pe atr c onco ogy erentfrom adult oncology?

    Different Cancers

    Few Carcinomas, More Leukemias

    Prediliction for Cancer at Unique Ages Growth Spurts

    Less Association With Environmental Factors

    Cancer is Less Common

    CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    29/31

    What long term health issues mightsurvivors of cancer have to deal with?

    Increased Risk of Second Cancers

    ,

    ?Elevated Genetic Risk?

    Long-Term Side Effects of Treatment Chemotherapy Heart Failure, Leukemia, Sensory

    Neuropathy, Renal Insufficiency, Sterility, Pulmonary

    Fibrosis etc.

    Radiation Dementia, Sarcomas, Leukemia, GrowthRetardation, Dry Mouth, Strictures, etc.

    urgery ymp e ema, a a sorp on, a n enance o

    Stomas, Dyspnea, etc.CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    30/31

    ow can you exp a n erences n t eincidence of cancer around the world?

    Different Environmental Exposures

    n ec ons

    HBV and Hepatoma in Asia

    EBV and Burkitts Lymphoma in Africa Diets

    Esophageal Cancer Belt Caspian Sea to China

    Relatively New in Third World

    Local Habits

    e e u s

    Access to Health Care

    Cervical Cancer in Third World CC-Pieters & Liebmann Feb 11 2011

  • 8/7/2019 cancer final review

    31/31

    Final Thoughts

    Get a Good Nights Sleep

    . ,

    abstract idea

    Obsess Less Over Trivia

    Worry More About Understanding the Concepts

    CC-Pieters & Liebmann Feb 11 2011